← Leaderboards
Chen Liu
University Of Florida
$8,980,679
Attributed
$12,974,254
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,974,254 · 18
By mechanism
R01$9,405,437 · 4
P30$1,152,333 · 2
K26$799,898 · 2
R21$716,224 · 2
K08$584,242 · 1
R03$143,790 · 1
Top collaborators
- Keith D Robertson14 shared
- Pallavi P. Gopal1 shared
Most similar at University Of Florida
Same institution · by research overlap
- Terence R. Flotte$26,412,339
- Rolf F Renne$15,821,379
- Erik K Flemington$23,678,004
- Nicholas Muzyczka$10,997,810
- Susana T Valente$35,884,894
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverTissuesBaseResourcesHepatitis CSamplingMediatingHepatitis C VirusHepatocyteChronicLiver DiseasesEnvironmentUnited StatesMalignant NeoplasmsGrowthEtiologyLaboratoriesPremalignantGeneticCirrhosisEpigenetic ProcessGenesGenetic TranscriptionDisease Progression
Grant awards (45)
Clinical - Translational Core$290,383
P30 · FY2025 · DK · contact PI
Yale Neuroscience Summer Scholars Program$56,603
R25 · FY2025 · NS · contact PI
Clinical - Translational Core$290,382
P30 · FY2024 · DK · contact PI
Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer$506,150
R01 · FY2022 · AA
Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer$506,150
R01 · FY2021 · AA
Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis$596,382
R01 · FY2020 · DK
Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer$506,150
R01 · FY2020 · AA
Biorepository and Histopathology$274,321
P30 · FY2020 · CA · contact PI
Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis$596,382
R01 · FY2019 · DK
Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer$506,150
R01 · FY2019 · AA
Biorepository and Histopathology$297,247
P30 · FY2019 · CA · contact PI
Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis$601,776
R01 · FY2018 · DK
Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer$520,900
R01 · FY2018 · AA
Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis$620,487
R01 · FY2017 · DK
Developmental pathways, environmental agents, and epigenetics in liver disease$576,972
R01 · FY2015 · AA
Developmental pathways, environmental agents, and epigenetics in liver disease$591,341
R01 · FY2014 · AA
Developmental pathways, environmental agents, and epigenetics in liver disease$560,612
R01 · FY2013 · AA
Molecular Target for Liver Cancer Diagnosis and Therapy$277,177
R01 · FY2013 · CA · contact PI
Mouse Immunopathology$153,646
K26 · FY2013 · OD · contact PI
Developmental pathways, environmental agents, and epigenetics in liver disease$610,974
R01 · FY2012 · AA
Molecular Target for Liver Cancer Diagnosis and Therapy$294,868
R01 · FY2012 · CA · contact PI
Mouse Immunopathology$161,563
K26 · FY2012 · OD · contact PI
Developmental pathways, environmental agents, and epigenetics in liver disease$630,122
R01 · FY2011 · AA
Molecular Target for Liver Cancer Diagnosis and Therapy$294,868
R01 · FY2011 · CA · contact PI
Mouse Immunopathology$161,563
K26 · FY2011 · RR · contact PI
Molecular Target for Liver Cancer Diagnosis and Therapy$303,988
R01 · FY2010 · CA · contact PI
Mouse Immunopathology$161,563
K26 · FY2010 · RR · contact PI
DIFFUSION TENSOR IMAGING AT HIGH FIELDS$18,500
P41 · FY2010 · RR · contact PI
Molecular Target for Liver Cancer Diagnosis and Therapy$303,988
R01 · FY2009 · CA · contact PI
Mouse Immunopathology$161,563
K26 · FY2009 · RR · contact PI
DIFFUSION TENSOR IMAGING AT HIGH FIELDS$18,046
P41 · FY2009 · RR · contact PI
KSPA FOR 3D PARALLEL IMAGING RECONSTRUCTION$16,825
P41 · FY2008 · RR · contact PI
Murine model for hepatitis C virus$177,602
R21 · FY2006 · AI · contact PI
Small molecules to treat alpha-1 antitrypsin deficiency$177,602
R21 · FY2006 · HL · contact PI
Role of liver cytokines in hepatitis C viral infection$123,172
K08 · FY2006 · DK · contact PI
Role of SOCS3 in HCV Interferon Resistance$71,040
R03 · FY2006 · DK · contact PI
OPTIMIZING PHASE CORRECTION FOR MULTI-SHOT DWI$31,178
P41 · FY2006 · RR · contact PI
IMPROVED HIGH-RESOLUTION SNAILS DTI WITH A SPIRAL-IN NAVIGATOR$31,178
P41 · FY2006 · RR · contact PI
Small molecules to treat alpha-1 antitrypsin deficiency$181,875
R21 · FY2005 · HL
Murine model for hepatitis C virus$179,145
R21 · FY2005 · AI
Role of liver cytokines in hepatitis C viral infection$123,172
K08 · FY2005 · DK
Role of SOCS3 in HCV Interferon Resistance$72,750
R03 · FY2005 · DK
Role of liver cytokines in hepatitis C viral infection$123,172
K08 · FY2004 · DK
Role of liver cytokines in hepatitis C viral infection$124,252
K08 · FY2003 · DK
Role of liver cytokines in hepatitis C viral infection$90,474
K08 · FY2002 · DK